POINT Biopharma Confirms No Supply Shortages of 177Lu-PNT2002 for the SPLASH Trial
INDIANAPOLIS, May 05, 2022 (GLOBE NEWSWIRE) -- POINT Biopharma Global Inc. (NASDAQ: PNT) (the “Company” or “POINT”), a company accelerating the discovery, development, and global access…